TRX4 (CAT#: Gly-002CL)

TRX4 is a monoclonal antibody that binds to a receptor found on all T cells called CD3, which is involved in normal T cell signaling. TRX4 is believed to inhibit the function of autoreactive T cells, which are important in propagating autoimmune diseases, while inducing regulatory T cell pathways that promote immunological tolerance and inhibit autoreactive disease activity. Tolerx is developing TRX4 to treat patients with type 1 diabetes, psoriasis and other autoimmune diseases such as rheumatoid arthritis.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Datasheet
  • MSDS
  • COA

Specifications

  • Type
  • Small Molecule
  • Mechanism of action
  • TRX4 is a monoclonal antibody that binds to a receptor found on all T cells called CD3, which is involved in normal T cell signaling. TRX4 is believed to inhibit the function of autoreactive T cells, which are important in propagating autoimmune diseases, while inducing regulatory T cell pathways that promote immunological tolerance and inhibit autoreactive disease activity.

References

  • Synonyms
  • Otelixizumab

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "CD3"

Select a product category from the dropdown menu below to view related products.
Please select product type
Mouse Antibodies Humanized Antibodies Chimeric Antibodies Blocking Antibodies ScFv Antibodies IgG Antibodies Fab Antibodies Single Domain Antibodies Agonistic Antibodies NHP Antibodies ScFv-Fc Chimeras IHC Kits & Antibodies

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for Gly-002CL. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare